Literature DB >> 31722452

Standardized Pathology Report for Colorectal Cancer, 2nd Edition.

Baek-Hui Kim1, Joon Mee Kim2, Gyeong Hoon Kang3, Hee Jin Chang4, Dong Wook Kang5, Jung Ho Kim3, Jeong Mo Bae3, An Na Seo6, Ho Sung Park7, Yun Kyung Kang8, Kyung-Hwa Lee9, Mee Yon Cho10, In-Gu Do11, Hye Seung Lee12, Hee Kyung Chang13, Do Youn Park14, Hyo Jeong Kang15, Jin Hee Sohn11, Mee Soo Chang16, Eun Sun Jung17, So-Young Jin18, Eunsil Yu15, Hye Seung Han19, Youn Wha Kim20.   

Abstract

The first edition of the 'Standardized Pathology Report for Colorectal Cancer,' which was developed by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists, was published 13 years ago. Meanwhile, there have been many changes in the pathologic diagnosis of colorectal cancer, pathologic findings included in the pathology report, and immunohistochemical and molecular pathology required for the diagnosis and treatment of colorectal cancer. In order to reflect these changes, we (GIP) decided to make the second edition of the report. The purpose of this standardized pathology report is to provide a practical protocol to the Korean pathologists, which could help diagnose and treat colorectal cancer patients. This report consists of 'standard data elements' and 'conditional data elements'. Basic pathologic findings and parts necessary for prognostication of CRC patients are classified as 'standard data elements,' while other prognostic factors and factors related to adjuvant therapy are classified as 'conditional data elements' so that each institution could select the contents according to the characteristics of the institution. The Korean version was also provided separately so that Korean pathologists can easily understand and use this report. We hope that this report will be helpful in the daily practice of colorectal cancer diagnosis.

Entities:  

Keywords:  Colorectal cancer; Pathology Report; Protocol; Standardization

Year:  2019        PMID: 31722452     DOI: 10.4132/jptm.2019.09.28

Source DB:  PubMed          Journal:  J Pathol Transl Med        ISSN: 2383-7837


  8 in total

1.  Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review.

Authors:  Muhammad Habiburrahman; Muhammad Prasetio Wardoyo; Stefanus Sutopo; Nur Rahadiani
Journal:  Mol Clin Oncol       Date:  2022-05-26

2.  Clinicopathological significance of Ki67 expression in colorectal cancer: A protocol of systematic review and meta-analysis.

Authors:  Jing Li; Zhi-Ye Liu; Hai-Bo Yu; Qing Xue; Wen-Jie He; Hai-Tao Yu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  Transformation of Pathology Reports Into the Common Data Model With Oncology Module: Use Case for Colon Cancer.

Authors:  Borim Ryu; Eunsil Yoon; Seok Kim; Sejoon Lee; Hyunyoung Baek; Soyoung Yi; Hee Young Na; Ji-Won Kim; Rong-Min Baek; Hee Hwang; Sooyoung Yoo
Journal:  J Med Internet Res       Date:  2020-12-09       Impact factor: 5.428

4.  Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer.

Authors:  Hyunseung Oh; Soon Gu Kim; Sung Uk Bae; Sang Jun Byun; Shin Kim; Jae-Ho Lee; Ilseon Hwang; Sun Young Kwon; Hye Won Lee
Journal:  J Pathol Transl Med       Date:  2021-11-16

5.  A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.

Authors:  Po-Chuan Chen; Yu-Min Yeh; Bo-Wen Lin; Ren-Hao Chan; Pei-Fang Su; Yi-Chia Liu; Chung-Ta Lee; Shang-Hung Chen; Peng-Chan Lin
Journal:  Biomedicines       Date:  2022-02-01

6.  Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).

Authors:  Zhengyang Yang; Xiao Zhang; Jie Zhang; Jiale Gao; Zhigang Bai; Wei Deng; Guangyong Chen; Yongbo An; Yishan Liu; Qi Wei; Jiagang Han; Ang Li; Gang Liu; Yi Sun; Dalu Kong; Hongwei Yao; Zhongtao Zhang
Journal:  BMC Cancer       Date:  2022-04-27       Impact factor: 4.638

7.  Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.

Authors:  Serenella Papparella; Maria Ines Crescio; Valeria Baldassarre; Barbara Brunetti; Giovanni P Burrai; Cristiano Cocumelli; Valeria Grieco; Selina Iussich; Lorella Maniscalco; Francesca Mariotti; Francesca Millanta; Orlando Paciello; Roberta Rasotto; Mariarita Romanucci; Alessandra Sfacteria; Valentina Zappulli
Journal:  Vet Sci       Date:  2022-07-13

8.  Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.

Authors:  Jeong-Ki Kim; Ye-Young Rhee; Jeong Mo Bae; Jung Ho Kim; Seong-Joon Koh; Hyun Jung Lee; Jong Pil Im; Min Jung Kim; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park; Ji Won Park; Gyeong Hoon Kang
Journal:  BMC Cancer       Date:  2022-08-06       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.